Gabapentin and pregabalin will become Schedule 3 Controlled Drugs in April 2019. NHS announced tightening of the law last year as the number of deaths linked to the illegal use of these drugs started raising concerns.

The Controlled Drug Accountable Officer’s Network (CDAON) has produced a detailed FAQ, underlining that there are no safe custody requirements for gabapentin and pregabalin even if they became Schedule 3 Controlled drugs and records are also need not be kept in the CD register.

Currently, these are prescription only medicines used to treat neuropathic pain. They also have mood-enhancing effects.